Please login to the form below
EU proposes vaccine-sharing mechanism with low-income countries
Mechanism could provide low-income countries with early access to COVID-19 vaccines
Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
Vaccine could be in use in Britain by September
WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”
Tedros Adhanom Ghebreyesus warns bilateral deals could threaten COVAX facility
Lilly partners with Merus on development of bispecific antibodies for cancer
As part of the deal, Merus could receive a total of up to around $1.6bn for three products
GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
Investigational PD-1 inhibitor is being studied in mismatch repair-deficient solid tumours
NHS is set to begin offering COVID-19 vaccinations to over-70s this week
Announcement comes as ten new vaccination centres open in England
Cambridge University develops DNA test for secondary infections in COVID-19 patients
Test can identify cases of ‘ventilator-associated pneumonia’
Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
'Temporary' reduction comes as companies bolster production capacity for the year
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
Companies will collaborate on novel drugs for autoimmune disorders
Q&A: Shairose Ebrahim
PME interviews integrated medhealth communication (imc) group's President and CEO
-
Q&A: Sarah MikhailovPME interviews Havas Life Medicom's Managing Partner
-
Q&A: Caroline GoslingPME interviews Rubica's Director of Culture & Engagement
-
PHE study finds people who have had COVID-19 can still transmit the virusProtection after infection lasts for at least five months on average
-
UK pharmacies to begin administering COVID-19 vaccinationsPharmacies will join the effort to bolster the UK’s mass vaccination rollout
-
New dosing option for AZ’s Imfinzi approved in the EU and UKAdditional option extends dosing from two weeks to four weeks
-
Bayer’s finerenone scores FDA priority review for chronic kidney disease FDA priority review is based on data from the phase 3 FIDELIO-DKD trial
-
Takeda and KSQ Therapeutics to develop immune-based cancer treatmentsCollaboration will utilise KSQ’s CRISPR-screening technology
-
Celltrion’s investigational mAb cuts COVID-19 recovery time Patients treated with mAb recovered 3.4 to 6.4 days quicker compared to placebo
-
J&J could launch its single-dose COVID-19 vaccine in MarchChief scientific officer Paul Stoffels said J&J is aiming for one billion doses in 2021
Latest appointments
-
Research Partnership appoints Hannah Osborn to MedTech director roleOsborne has previously worked at Ipsos and IQVIA
-
New hire and promotions announced at Evoke KYNEKaren Urban joins Evoke as a vice president
-
New executive appointments at Synergy VisionEileen Gallagher and Karine Henderson take on new leadership roles
-
Nucleus Global announces a trio of promotionsDan Bridges is appointed as new chief executive officer
-
Publicis Health appoints Kara Dugan as president of Razorfish HealthDugan has spent over a decade at Publicis Health
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Senior Account Manager
-
Competitive
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Sanofi, GSK delay COVID-19 vaccine trial after underwhelming results in elderly participants
- PHE study finds people who have had COVID-19 can still transmit the virus
- New study identifies drugs that are safe to use in COVID-19 treatment
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- PHE study finds people who have had COVID-19 can still transmit the virus
- CureVac set to begin phase 3 COVID-19 vaccine study in healthcare workers
- EU proposes vaccine-sharing mechanism with low-income countries
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- WHO’s director-general deems vaccine nationalism a “catastrophic moral failure”
- Lilly partners with Merus on development of bispecific antibodies for cancer
- Medical research charities need our help – support is needed to continue funding life-saving research and improving lives
- Research Partnership appoints Hannah Osborn to MedTech director role
PMHub
Viseven
Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...
Latest intelligence
- Sourcing R&D innovation: why pharma companies need to evolve their business models
- Recent years have seen a significant shift in drug development to specialty areas...
- 2020 - a year to remember or forget?
- 2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
- The search for effective drug treatments for COVID-19
- PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
Quick links
Infographics
